Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
05.11.23 | Celldex Therapeutics, Inc.: Celldex Therapeutics Presents Positive Data from Prurigo Nodularis Phase 1b Study Demonstrating Meaningful Reduction in Itch and Skin Clearing with Single Dose 3.0 mg/kg Barzolvolimab | 206 | GlobeNewswire (Europe) | - Response observed as early as week 1 and durable for up to 16 weeks -- Data support important role for mast cells in the pathogenesis of PN and potentially other chronic itch indications -- Phase... ► Artikel lesen | |
05.11.23 | Tenaris SA: Tenaris to Commence a USD 300 million First Tranche of its USD 1.2 Billion Share Buyback Program | 615 | GlobeNewswire (Europe) | LUXEMBOURG, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) ("Tenaris") announced today that pursuant to its Share Buyback Program (the "Program") announced on... ► Artikel lesen | |
05.11.23 | MoonLake Immunotherapeutics AG: MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody® sonelokimab in active psoriatic arthritis | 610 | GlobeNewswire (Europe) | MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody® sonelokimab in active psoriatic arthritis
First placebo-controlled randomized trial in active psoriatic arthritis... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 3.323 |
EVOTEC | 2.660 |
TUI | 2.095 |
NEL | 1.334 |
BAYER | 1.163 |
PLUG POWER | 1.157 |
NVIDIA | 1.155 |
RHEINMETALL | 1.071 |
AMC ENTERTAINMENT | 1.041 |
DEUTSCHE BANK | 978 |
SIEMENS ENERGY | 947 |
RENK GROUP | 880 |
REDCARE PHARMACY | 732 |
COMMERZBANK | 731 |
HEIDELBERGER DRUCK | 707 |
ALIBABA | 693 |
VOLKSWAGEN | 680 |
E.ON | 621 |
BARRICK GOLD | 620 |
BYD | 598 |
RWE | 591 |
TESLA | 578 |
DEUTSCHE LUFTHANSA | 569 |
SIEMENS | 566 |
AIXTRON SE | 560 |